Collegium Pharmaceutical (COLL)
(Real Time Quote from BATS)
$36.42 USD
+0.58 (1.62%)
Updated Apr 26, 2024 01:47 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *AMC5/9/24 |
---|---|
Current Quarter | 1.50 |
EPS Last Quarter | 1.58 |
Last EPS Surprise | 18.80% |
ABR | 1.83 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 6.16 |
Next Year | 6.76 |
EPS (TTM) | 5.50 |
P/E (F1) | 5.82 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 148.00M | 142.36M | 582.52M | 595.30M |
# of Estimates | 4 | 4 | 5 | 5 |
High Estimate | 149.50M | 145.17M | 586.47M | 605.80M |
Low Estimate | 146.20M | 139.90M | 579.50M | 580.30M |
Year ago Sales | 144.77M | 135.55M | 566.77M | 582.52M |
Year over Year Growth Est. | 2.23% | 5.02% | 2.78% | 2.19% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.50 | 1.44 | 6.16 | 6.76 |
# of Estimates | 4 | 4 | 5 | 5 |
Most Recent Consensus | 1.52 | 1.46 | 6.18 | 6.75 |
High Estimate | 1.58 | 1.54 | 6.58 | 7.52 |
Low Estimate | 1.38 | 1.33 | 5.48 | 5.85 |
Year ago EPS | 1.32 | 1.26 | 5.47 | 6.16 |
Year over Year Growth Est. | 13.64% | 14.29% | 12.61% | 9.64% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.50 | 1.44 | 6.16 | 6.76 |
7 Days Ago | 1.50 | 1.44 | 6.16 | 6.76 |
30 Days Ago | 1.50 | 1.44 | 6.16 | 6.76 |
60 Days Ago | 1.43 | 1.38 | 6.07 | 6.90 |
90 Days Ago | 1.37 | 1.38 | 6.11 | 6.63 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.50 | 1.44 | 6.16 | 6.76 |
Zacks Consensus Estimate | 1.50 | 1.44 | 6.16 | 6.76 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.58 | 1.34 | 1.26 | 1.32 | NA |
Estimate | 1.33 | 1.24 | 1.22 | 1.32 | NA |
Difference | 0.25 | 0.10 | 0.04 | 0.00 | 0.10 |
Surprise | 18.80% | 8.06% | 3.28% | 0.00% | 7.54% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more